AARTI DRUGS LTD.
Market Cap.(`)
|
4665.70 Cr.
|
P/BV
|
3.91
|
Book Value (`)
|
129.63
|
52 Week High/Low ( ` )
|
646/423
|
FV/ML
|
10/1
|
P/E(X)
|
28.06
|
Book Closure
|
06/02/2024
|
EPS (`)
|
18.09
|
Div Yield (%)
|
0.20
|
(` in Crs.)
You can view the
Consolidated
Income Statement
for the last 5 years.
Months | 12 | 12 | 12 | 12 | 12 |
Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | |
| | | | | |
INCOME | | | | | |
Revenue From Operations [Net] | 2716.05 | 2488.65 | 2154.78 | 1806.09 | 1560.94 |
Total Operating Revenues | 2716.05 | 2488.65 | 2154.78 | 1806.09 | 1560.94 |
| | | | | |
Other Income | 2.19 | 11.32 | 4.53 | 1.48 | 2.41 |
Total Revenue | 2718.25 | 2499.96 | 2159.30 | 1807.57 | 1563.35 |
| | | | | |
EXPENSES | | | | | |
Cost Of Materials Consumed | 1768.97 | 1666.36 | 1221.52 | 1141.92 | 998.90 |
Purchase Of Stock-In Trade | 121.29 | 108.57 | 111.24 | 88.32 | 44.25 |
Operating And Direct Expenses | 334.09 | 295.98 | 233.43 | 222.87 | 187.29 |
Changes In Inventories Of FG,WIP And Stock-In Trade | -1.75 | -86.08 | -11.72 | -51.28 | 16.82 |
Employee Benefit Expenses | 92.02 | 82.81 | 80.50 | 69.36 | 60.92 |
Finance Costs | 33.29 | 20.75 | 22.96 | 33.73 | 39.96 |
Depreciation And Amortisation Expenses | 50.32 | 50.05 | 49.88 | 48.75 | 42.56 |
Other Expenses | 95.83 | 91.58 | 82.71 | 73.09 | 45.39 |
Total Expenses | 2494.07 | 2230.01 | 1790.52 | 1626.75 | 1436.09 |
| | | | | |
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 224.18 | 269.96 | 368.79 | 180.82 | 127.26 |
| | | | | |
Exceptional Items | 0.00 | 0.00 | 0.22 | 4.47 | 3.77 |
Profit/Loss Before Tax | 224.18 | 269.96 | 369.01 | 185.29 | 131.02 |
| | | | | |
Tax Expenses-Continued Operations | | | | | |
Current Tax | 58.86 | 69.74 | 93.00 | 46.04 | 33.72 |
Less: MAT Credit Entitlement | 0.00 | 0.00 | -0.08 | 0.00 | 0.08 |
Deferred Tax | -1.03 | -4.78 | -4.46 | -9.45 | 8.71 |
Tax For Earlier Years | 0.00 | 0.00 | 0.00 | 7.30 | -1.08 |
Total Tax Expenses | 57.82 | 64.96 | 88.62 | 43.89 | 41.27 |
Profit/Loss After Tax And Before ExtraOrdinary Items | 166.36 | 205.00 | 280.40 | 141.40 | 89.75 |
| | | | | |
Profit/Loss From Continuing Operations | 166.36 | 205.00 | 280.40 | 141.40 | 89.75 |
| | | | | |
Profit/Loss For The Period | 166.36 | 205.00 | 280.40 | 141.40 | 89.75 |
| | | | | |
Minority Interest | -0.05 | 0.04 | 0.01 | 0.00 | 0.00 |
Consolidated Profit/Loss After MI And Associates | 166.31 | 205.04 | 280.41 | 141.40 | 89.75 |
| | | | | |
OTHER INFORMATION | | | | | |
| | | | | |
EARNINGS PER SHARE | | | | | |
Basic EPS (Rs.) | 17.97 | 22.12 | 30.09 | 60.57 | 38.48 |
Diluted EPS (Rs.) | 17.97 | 22.12 | 30.09 | 60.57 | 38.48 |
| | | | | |
DIVIDEND AND DIVIDEND PERCENTAGE | | | | | |
Equity Share Dividend | 9.26 | 9.26 | 23.30 | 6.99 | 2.36 |
Tax On Dividend | 0.00 | 0.00 | 0.00 | 1.44 | 0.48 |